GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Price-to-Free-Cash-Flow
中文

Bausch Health (TSX:BHC) Price-to-Free-Cash-Flow : 4.20 (As of Apr. 24, 2024)


View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Price-to-Free-Cash-Flow?

As of today (2024-04-24), Bausch Health's share price is C$11.73. Bausch Health's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$2.80. Hence, Bausch Health's Price-to-Free-Cash-Flow Ratio for today is 4.20.

The historical rank and industry rank for Bausch Health's Price-to-Free-Cash-Flow or its related term are showing as below:

TSX:BHC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.44   Med: 6.56   Max: 58.59
Current: 4.17

During the past 13 years, Bausch Health's highest Price-to-Free-Cash-Flow Ratio was 58.59. The lowest was 1.44. And the median was 6.56.

TSX:BHC's Price-to-Free-Cash-Flow is ranked better than
94.11% of 492 companies
in the Drug Manufacturers industry
Industry Median: 21.575 vs TSX:BHC: 4.17

Bausch Health's Free Cash Flow per Share for the three months ended in Dec. 2023 was C$0.90. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$2.80.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -1.20% per year.

During the past 13 years, Bausch Health's highest 3-Year average Free Cash Flow per Share Growth Rate was 241.90% per year. The lowest was -66.20% per year. And the median was -0.45% per year.


Bausch Health Price-to-Free-Cash-Flow Historical Data

The historical data trend for Bausch Health's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Price-to-Free-Cash-Flow Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.50 9.13 8.57 - 3.80

Bausch Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 3.38 3.80

Competitive Comparison of Bausch Health's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bausch Health's Price-to-Free-Cash-Flow falls into.



Bausch Health Price-to-Free-Cash-Flow Calculation

Bausch Health's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=11.73/2.796
=4.20

Bausch Health's Share Price of today is C$11.73.
Bausch Health's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.80.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Bausch Health  (TSX:BHC) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Bausch Health Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bausch Health's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (TSX:BHC) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Bausch Health (TSX:BHC) Headlines

From GuruFocus